However, mI abnormality is suggested as an early event in the progression of AD pathology, as elevated mI/Cr was observed in APOE ε4 carriers compared with noncarriers in CU subjects with normal CSF Aβ42 levels [26]. Here, APOE is linked to Alzheimer disease.